Expand INBS Menu
INBS MENU

INBS Latest Press Releases

-- June 4, 2026 --

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 Globe Newswire 8:30 AM

-- June 2, 2026 --

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission Globe Newswire 8:30 AM

-- May 13, 2026 --

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year Globe Newswire 8:30 AM

-- April 20, 2026 --

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results Globe Newswire 9:15 AM

-- April 17, 2026 --

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified Globe Newswire 8:30 AM

-- April 2, 2026 --

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market Globe Newswire 8:30 AM

-- March 26, 2026 --

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant Globe Newswire 8:30 AM

-- February 25, 2026 --

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry Globe Newswire 8:45 AM

-- February 24, 2026 --

Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout Globe Newswire 8:45 AM

-- February 12, 2026 --

Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year Globe Newswire 8:30 AM

-- February 5, 2026 --

Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year Globe Newswire 8:30 AM

-- January 28, 2026 --

Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes